Monoclonal Antibody Therapy Market Size, Share & Industry Analysis, By Type (Human mAb, Humanized mAb, Chimeric mAb, and Murine mAb), By Application (Cancer, Autoimmune Diseases, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI102734

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 14.8% from 2024-2032
Unit	Value (USD Billion)
Segmentation	By Type Human mAb Humanized mAb Chimeric mAb Murine mAb By Application Cancer Autoimmune Diseases Others By Distribution Channel Hospital Pharmacy Retail Pharmacy Online Pharmacy By Geography North America (Type, Application, Distribution Channel, and Country) U.S. Canada Europe (Type, Application, Distribution Channel, and Country/Sub-region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia-Pacific (Type, Application, Distribution Channel, and Country/Sub-region) Japan China India Australia Southeast Asia Rest of Asia Pacific Latin America (Type, Application, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (Type, Application, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of the Middle East & Africa